Literature DB >> 6183349

Modulation of IL 2-dependent growth of mouse NK cells by interferon and T lymphocytes.

C Riccardi, B M Vose, R B Herberman.   

Abstract

The regulatory role of interferon (IFN) on the growth of mouse natural killer (NK) cells in the presence of interleukin 2 (IL 2) was analyzed by the limiting dilution assay. Pretreatment for 5 hr with IFN (600 U/ml) was able to augment the frequency of proliferating cells and NK effector cells when spleen cells of BALB/c nu/+ and BALB/c nu/nu were cultured for 7 days in the presence of IL 2. When IFN was present during the 7-day culture period, we again found an increase in proliferative and cytotoxic frequencies in cultures of spleen cells from nude mice, but in contrast, found a decrease in these frequencies in cultures of spleen cells from euthymic mice. Addition of irradiated (3000 R) spleen or thymus feeder cells from euthymic mice to the nu/nu cultures caused an inhibitory activity of IFN also on nu/nu cells. These data indicate that IFN can have both positive and negative regulatory effects on the in vitro growth and differentiation of mouse NK cells and that the inhibitory effects are mediated via T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6183349

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  Natural killer cells and autoimmunity.

Authors:  E Grunebaum; E Malatzky-Goshen; Y Shoenfeld
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

2.  Reduced number of natural killer cells in patients with pathological hyperprolactinemia.

Authors:  R Gerli; P Rambotti; I Nicoletti; S Orlandi; G Migliorati; C Riccardi
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

3.  Suppression of natural killer cell activity in mouse spleen lymphocytes by several dopamine receptor antagonists.

Authors:  S J Won; Y C Chuang; W T Huang; H S Liu; M T Lin
Journal:  Experientia       Date:  1995-04-15

4.  Natural killer-cell activity, interferon-alpha 2 production, and interleukin-2 production in cyclosporine-treated and conventionally immunosuppressed human allograft recipients.

Authors:  P J Guillou; G R Giles; C W Ramsden
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

5.  Natural killer cell-mediated activity in mixed connective tissue disease and its response to induction by interleukin-2.

Authors:  R González-Amaro; J Alcocer-Varela; E Martínez-Cordero; D Alarcón-Segovia
Journal:  J Clin Immunol       Date:  1984-07       Impact factor: 8.317

6.  Absence of a role for natural killer cells in the control of acute infection by Toxoplasma gondii oocysts.

Authors:  H P Hughes; L H Kasper; J Little; J P Dubey
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

7.  Modulation of natural killer activity by thymosin alpha 1 and interferon.

Authors:  C Favalli; T Jezzi; A Mastino; C Rinaldi-Garaci; C Riccardi; E Garaci
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

8.  Interleukin 2 augmentation of natural killer cell activity in homosexual men with acquired immune deficiency syndrome.

Authors:  M M Reddy; N Pinyavat; M H Grieco
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

9.  Interleukin-2-induced activation of natural killer activity in spleen cells from old and young mice.

Authors:  R K Saxena; Q B Saxena; W H Adler
Journal:  Immunology       Date:  1984-04       Impact factor: 7.397

10.  Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells.

Authors:  W H Chambers; N L Vujanovic; A B DeLeo; M W Olszowy; R B Herberman; J C Hiserodt
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.